Cite
HARVARD Citation
Dulai, P. et al. (2020). Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. American journal of gastroenterology. pp. 885-894. [Online].